Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder

Primary Sponsor

Urological Society of Australasia

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

67

Trial Chairperson

Dr Kumar Gogna, QRI Mater Centre, QLD

Trial Contact

Kumar Gogna

Clinical Trial Registration

Related Post

17 November, 2026

Every kilometre counts: TROG supporters go the distance for cancer research

LATEST NEWS: 17 November 2026 From early morning walks

10 November, 2026

Golfers tee off for annual TROG fundraiser

LATEST NEWS: 10 November 2026 The Myall Coast Veteran